|
|
| | A3AR agonist 5 Basic information |
| Product Name: | A3AR agonist 5 | | Synonyms: | A3AR agonist 5;Bicyclo[3.1.0]hexane-2,3-diol, 4-(5-chloro-7-methylimidazo[4,5-b]pyrrolo[2,3-d]pyridin-3(8H)-yl)-1-(1H-imidazol-2-yl)-, (1R,2R,3S,4R,5S)- | | CAS: | 3032475-38-7 | | MF: | C18H17ClN6O2 | | MW: | 384.82 | | EINECS: | | | Product Categories: | | | Mol File: | 3032475-38-7.mol |  |
| | A3AR agonist 5 Chemical Properties |
| Boiling point | 787.9±70.0 °C(predicted) | | density | 1.98±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 12.03±0.50(predicted) |
| | A3AR agonist 5 Usage And Synthesis |
| Uses | A3AR agonist 5 (Compound 6b) is a A3 adenosine receptor (A3AR) activator, with EC50 and Ki values of 0.14 nM and 6.36 nM for cAMP and hA3, respectively. A3AR agonist 5 can be used in pain and inflammatory research[1]. | | References | [1] Cohen CJ, et al. Adenosine analogs for the treatment of disease. WO2024064701A2. 2024-03-28 |
| | A3AR agonist 5 Preparation Products And Raw materials |
|